Anthonie WA Lensing

1.3k total citations · 1 hit paper
13 papers, 952 citations indexed

About

Anthonie WA Lensing is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine and Hematology. According to data from OpenAlex, Anthonie WA Lensing has authored 13 papers receiving a total of 952 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Internal Medicine, 11 papers in Cardiology and Cardiovascular Medicine and 9 papers in Hematology. Recurrent topics in Anthonie WA Lensing's work include Venous Thromboembolism Diagnosis and Management (13 papers), Atrial Fibrillation Management and Outcomes (11 papers) and Blood Coagulation and Thrombosis Mechanisms (9 papers). Anthonie WA Lensing is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (13 papers), Atrial Fibrillation Management and Outcomes (11 papers) and Blood Coagulation and Thrombosis Mechanisms (9 papers). Anthonie WA Lensing collaborates with scholars based in Germany, Netherlands and United States. Anthonie WA Lensing's co-authors include Martin H. Prins, Paolo Prandoni, Rupert Bauersachs, HR Büller, Hervé Decousus, Philip S. Wells, Bruce L. Davidson, Bonno van Bellen, Timothy Brighton and Gary E. Raskob and has published in prestigious journals such as The Lancet, Blood and Thrombosis and Haemostasis.

In The Last Decade

Anthonie WA Lensing

13 papers receiving 913 citations

Hit Papers

Oral rivaroxaban versus standard therapy for the treatmen... 2013 2026 2017 2021 2013 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies
    2013 427 citations Martin H. Prins, Anthonie WA Lensing et al. Thrombosis Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anthonie WA Lensing Germany 12 862 736 242 233 128 13 952
Colin Chesterman Australia 4 735 0.9× 567 0.8× 204 0.8× 353 1.5× 136 1.1× 4 940
A.G.M. van den Belt Netherlands 4 805 0.9× 609 0.8× 223 0.9× 348 1.5× 139 1.1× 4 910
Cathy Emery United States 9 856 1.0× 529 0.7× 181 0.7× 286 1.2× 219 1.7× 11 936
Nuala Peter Germany 8 715 0.8× 694 0.9× 141 0.6× 153 0.7× 79 0.6× 10 935
Marc Carrier Canada 9 784 0.9× 539 0.7× 222 0.9× 245 1.1× 185 1.4× 15 891
Corrado Pattacini Italy 13 702 0.8× 577 0.8× 507 2.1× 267 1.1× 94 0.7× 24 1.1k
Hilde Skuterud Wik Norway 17 660 0.8× 322 0.4× 152 0.6× 314 1.3× 152 1.2× 39 733
Eugenio Bucherini Italy 14 778 0.9× 538 0.7× 174 0.7× 393 1.7× 168 1.3× 28 960
M de Rijk Netherlands 3 940 1.1× 497 0.7× 211 0.9× 578 2.5× 259 2.0× 4 1000
C. Falgá Spain 12 557 0.6× 426 0.6× 88 0.4× 152 0.7× 152 1.2× 20 643

Countries citing papers authored by Anthonie WA Lensing

Since Specialization
Citations

This map shows the geographic impact of Anthonie WA Lensing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthonie WA Lensing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthonie WA Lensing more than expected).

Fields of papers citing papers by Anthonie WA Lensing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anthonie WA Lensing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthonie WA Lensing. The network helps show where Anthonie WA Lensing may publish in the future.

Co-authorship network of co-authors of Anthonie WA Lensing

This figure shows the co-authorship network connecting the top 25 collaborators of Anthonie WA Lensing. A scholar is included among the top collaborators of Anthonie WA Lensing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anthonie WA Lensing. Anthonie WA Lensing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Young, Guy, Anthonie WA Lensing, Paul Monagle, Christoph Male, & Dagmar Kubitza. (2019). Rivaroxaban for Treatment of Pediatric Venous Thromboembolism. an Einstein-Jr Phase 3 Dose-Exposure-Response Evaluation. Blood. 134(Supplement_1). 164–164. 7 indexed citations
2.
Yamada, Norikazu, Atsushi Hirayama, Hideaki Maeda, et al.. (2015). Oral rivaroxaban for Japanese patients with symptomatic venous thromboembolism – the J-EINSTEIN DVT and PE program. Thrombosis Journal. 13(1). 11–11. 79 indexed citations
3.
Bauersachs, Rupert, Anthonie WA Lensing, Martin H. Prins, et al.. (2014). Rivaroxaban versus enoxaparin/vitamin K antagonist therapy in patients with venous thromboembolism and renal impairment. Thrombosis Journal. 12(1). 25–25. 50 indexed citations
4.
Wells, Philip S., Martin Gebel, Martin H. Prins, Bruce L. Davidson, & Anthonie WA Lensing. (2014). Influence of statin use on the incidence of recurrent venous thromboembolism and major bleeding in patients receiving rivaroxaban or standard anticoagulant therapy. Thrombosis Journal. 12(1). 26–26. 22 indexed citations
5.
Wang, Yuqi, Chen Wang, Zhong Chen, et al.. (2013). Rivaroxaban for the treatment of symptomatic deep-vein thrombosis and pulmonary embolism in Chinese patients: a subgroup analysis of the EINSTEIN DVT and PE studies. Thrombosis Journal. 11(1). 25–25. 24 indexed citations
6.
Prins, Martin H., Anthonie WA Lensing, Rupert Bauersachs, et al.. (2013). Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies. Thrombosis Journal. 11(1). 21–21. 427 indexed citations breakdown →
7.
Prins, Martin H. & Anthonie WA Lensing. (2013). Derivation of the non-inferiority margin for the evaluation of direct oral anticoagulants in the treatment of venous thromboembolism. Thrombosis Journal. 11(1). 13–13. 19 indexed citations
8.
Bellen, Bonno van, Martin Prins, Luke Bamber, Maria Wang, & Anthonie WA Lensing. (2012). Reduction in Initial Length of Stay with Rivaroxaban Single-Drug Regimen versus LMWH-VKA Standard of Care: Findings from the EINSTEIN Trial Program. Blood. 120(21). 3419–3419. 11 indexed citations
9.
Prins, Martin, Luke Bamber, Stefan Cano, et al.. (2012). Patient-Reported Treatment Satisfaction with Oral Rivaroxaban Versus Standard Therapy in the Treatment of Acute Symptomatic Pulmonary Embolism. Blood. 120(21). 1163–1163. 15 indexed citations
10.
Lensing, Anthonie WA, et al.. (2009). Pharmacokinetic and clinical data supporting the use of fondaparinux 1.5 mg once daily in the prevention of venous thromboembolism in renally impaired patients. Blood Coagulation & Fibrinolysis. 20(2). 114–121. 35 indexed citations
11.
Lensing, Anthonie WA, Paolo Prandoni, Martin H. Prins, & HR Büller. (1999). Deep-vein thrombosis. The Lancet. 353(9151). 479–485. 163 indexed citations
12.
Prandoni, Paolo, et al.. (1998). Long-term outcomes after deep venous thrombosis of the lower extremities. Vascular Medicine. 3(1). 57–60. 48 indexed citations
13.
Büller, Harry R., Anthonie WA Lensing, Jack Hirsh, & Jan W. ten Cate. (1991). Deep Vein Thrombosis: New Non-Invasive Diagnostic Tests. Thrombosis and Haemostasis. 66(1). 133–137. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Colin Chesterman Breakdown of academic impact, for papers by A.G.M. van den Belt Breakdown of academic impact, for papers by Cathy Emery Breakdown of academic impact, for papers by Nuala Peter Breakdown of academic impact, for papers by Marc Carrier Breakdown of academic impact, for papers by Corrado Pattacini Breakdown of academic impact, for papers by Hilde Skuterud Wik Breakdown of academic impact, for papers by Eugenio Bucherini Breakdown of academic impact, for papers by M de Rijk Breakdown of academic impact, for papers by C. Falgá
Rankless by CCL
2026